Canaccord Analyst Initiates Coverage on Tilray Brands, Inc. (TLRY)

Tilray Brands, Inc. (NASDAQ:TLRY) is among the Best Marijuana Stocks. 

Canaccord analyst Kenric Tyghe began covering Tilray Brands, Inc. (NASDAQ:TLRY) on January 27, 2026, according to TheFly, with a C$13 price target and a Hold rating. According to the company, despite legislative obstacles and structural inefficiencies, the Canadian cannabis industry continues to set the standard for legal cannabis commerce worldwide. The firm was ranked as the fourth-largest craft brewer in the US and the biggest cannabis company in Canada based on revenue. Canaccord attributed its Hold rating to a challenging beer market.

Following Tilray Brands, Inc. (NASDAQ:TLRY)'s second-quarter results, Roth Capital retained its Neutral rating. It trimmed its price objective to $10 from $20 on January 20, 2026. The company cited CC Pharma's inflection, Canadian adult-use results, and foreign sales as signals of growing momentum. As stated by Roth, the firm’s future depends on the results of US legislation. The analyst also mentioned the corporation’s vulnerability to intoxicating hemp products, which, if not addressed, may result in a prohibition on November 13, 2026.

Tilray Brands, Inc. (NASDAQ:TLRY) is a consumer packaged goods firm that specializes in the production, processing, and marketing of cannabis products globally, as well as medicinal cannabis research. It operates in four segments: cannabis, distribution, beverage, and wellness.

While we acknowledge the potential of TLRY as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 20 Best AI Stock To Buy Now and 30 Best Stocks to Buy Now According to Billionaires.

Disclosure: None.